Business Context and Reporting Period
Company: Calumet, Inc. (CLMT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Calumet manufactures, formulates, and markets specialty branded products and renewable fuels. Operations are managed through four segments: Specialty Products and Solutions, Performance Brands, Montana/Renewables, and Corporate. The company operates twelve facilities across North America.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Sales (Revenue) | $1,078.0M | $1,100.4M | $3,098.5M | $3,239.9M |
| Gross Profit | $373.7M | $4.9M | $248.7M | $147.2M |
| Operating Income | $322.9M | ($57.1M) | $173.2M | ($14.6M) |
| Net Income (Loss) | $313.4M | ($100.6M) | $3.5M | ($181.3M) |
| EPS (Basic & Diluted) | $3.61 | ($1.18) | $0.04 | ($2.21) |
| Adjusted EBITDA | $69.6M | $59.8M | $162.8M | $162.7M |
| Cash & Equivalents | $94.6M | $38.1M | $94.6M | $38.1M |
| Total Debt (Carrying Value) | $2,302.6M | $2,100.2M | $2,302.6M | $2,100.2M |
| Total Liquidity | $384.4M | $289.8M | $384.4M | $289.8M |
Note: Liquidity includes unrestricted cash ($94.6M), restricted cash ($80.0M), and revolver availability ($209.8M).
Material Changes vs. Prior Period
- Profitability Surge: Q3 2025 Net Income of $313.4M represents a significant turnaround from a $100.6M loss in Q3 2024. This was primarily driven by a $303.1M non-cash gain related to the de-recognition of the Renewable Identification Numbers (RINs) obligation following EPA Small Refinery Exemption (SRE) decisions in August 2025.
- Asset Sale: The company recorded a $55.8M gain on the sale of the industrial portion of the Royal Purple business in Q1 2025, contributing to the nine-month results.
- Debt Restructuring: The company incurred $47.2M in debt extinguishment costs during the nine months ended September 30, 2025, associated with refinancing activities, including the termination of MRL financing arrangements and partial redemption of 2026 Notes.
- DOE Loan Funding: In February 2025, the company received the first tranche of a $1.44B DOE Loan Guarantee ($781.8M) to fund the MaxSAF project at the Montana Renewables facility.
- Segment Performance: Specialty Products and Solutions Adjusted EBITDA increased to $80.2M (Q3 2025) from $50.7M (Q3 2024) due to record production and improved margins. Montana/Renewables Adjusted EBITDA with Tax Attributes was $17.1M (Q3 2025) versus $14.6M (Q3 2024).
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management expects the current margin environment for specialty and fuel products to continue into Q4 2025, offset by normal seasonal weakness. Demand for renewable fuels remains strong, driven by federal policy and corporate decarbonization targets.
- Capital Expenditures: Forecasted total capital expenditures for 2025 are $60M to $90M, excluding the MaxSAF project. MaxSAF funding is expected to come from MRL cash flows and the DOE Facility.
- Regulatory Risks (RINs): While the company received SREs for 2018-2024, the 2025 program year decision is pending. The company faces litigation risks regarding EPA decisions. A $1.00 increase in RIN prices could negatively impact Net Income by approximately $65.0M annually.
- Internal Control Weakness: The company identified a material weakness in internal controls over financial reporting related to the classification of cash flows (operating vs. financing). This led to the restatement of Q1 and Q2 2025 financial statements. Remediation is ongoing.
- Legislative Impact: The "One Big Beautiful Bill Act" (OBBB) passed in July 2025 extends clean fuel production credits but eliminates special rates for Sustainable Aviation Fuel (SAF) after 2025. Management does not expect a material impact on 2025 results.
Investor Verification Checklist
- RINs Obligation Status: Verify the final status of the 2025 Small Refinery Exemption (SRE) petition and the potential for future RIN purchase costs if exemptions are denied.
- DOE Loan Milestones: Monitor the achievement of milestones required to draw the second tranche ($658M) of the DOE Loan for the MaxSAF project.
- Internal Control Remediation: Review future filings for confirmation that the material weakness regarding cash flow classification has been fully remediated and validated.
- Debt Covenants: Confirm continued compliance with the springing financial covenants in the revolving credit facility, specifically the Fixed Charge Coverage Ratio, given the high debt load.
- Segment Margins: Assess the sustainability of the improved margins in the Specialty Products and Solutions segment, which were heavily influenced by the non-cash RINs gain.